Harrington Discovery Institute supports the efforts of innovative scientists to advance discoveries that will improve lives of patients. In a similar mission, Alzheimer’s Drug Discovery Foundation (ADDF) provides funding to accelerate scientists’ efforts to develop drugs to prevent, treat and cure Alzheimer’s disease, or related dementias.
In 2013, the ADDF-Harrington Scholar Program was established. This program is a mission-aligned partnership, leveraging our combined expertise and resources to advance highly promising Alzheimer’s disease discovery projects, conducted in academic medical institutions nationwide.
Funded from ADDF, ADDF-Harrington Scholars are provided strategic advising and mentoring from experts in pharmaceutical development through Harrington Discovery Institute’s Therapeutics Development Center. ADDF-Harrington Scholars have facilitated access to BioMotiv and Advent-Harrington, for-profit impact vehicles, associated with The Harrington Project.